MedPath
NMPA Approval

Ranitidine Hydrochloride Capsules

国药准字H33020510

December 31, 2024

Drug Information

盐酸雷尼替丁胶囊

胶囊剂

0.15克(以雷尼替丁计)

化学药品

December 31, 2024

Company Information

Applicant Company

浙江开化工业园区泰康路1号

Manufacturing Company

浙江开化工业园区泰康路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸雷尼替丁胶囊 - NMPA 批准文号 | MedPath